Published in Can Fam Physician on February 01, 2012
Extensive bilateral intracranial calcifications: a case of iatrogenic hypoparathyroidism. Case Rep Med (2013) 0.87
Factors predicting post-thyroidectomy hypoparathyroidism recovery. World J Surg (2014) 0.85
Atypical Parathyroid Adenoma Complicated with Protracted Hungry Bone Syndrome after Surgery: A Case Report and Literature Review. Case Rep Endocrinol (2015) 0.75
Endocrine check-up in adolescents and indications for referral: A guide for health care providers. Indian J Endocrinol Metab (2014) 0.75
Hypocalcemia in acute pancreatitis revisited. Indian J Crit Care Med (2016) 0.75
Parameters of Calcium Metabolism Fluctuated during Initiation or Changing of Antipsychotic Drugs. Psychiatry Investig (2015) 0.75
Severe hypocalcemia and life-threatening ventricular arrhytmias: case report and proposal of a diagnostic and therapeutic algorithm. Clin Cases Miner Bone Metab (2015) 0.75
Site-Specific Variations in Bone Mineral Density under Systemic Conditions Inducing Osteoporosis in Minipigs. Front Physiol (2017) 0.75
Vitamin D deficiency. N Engl J Med (2007) 59.34
High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc (2006) 8.78
Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr (2003) 6.50
Redefining vitamin D insufficiency. Lancet (1998) 5.26
Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab (2004) 3.71
Clinical practice. Hypoparathyroidism. N Engl J Med (2008) 3.29
Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial. J Clin Oncol (2005) 3.09
A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics (2003) 2.88
Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr (1998) 2.72
Diagnosis and management of hypocalcaemia. BMJ (2008) 2.71
Severe hypocalcaemia after being given intravenous bisphosphonate. BMJ (2004) 2.59
Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab (2003) 2.53
Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res (2011) 2.30
Lesson of the week: florid rickets associated with prolonged breast feeding without vitamin D supplementation. BMJ (1999) 2.19
Hyperparathyroid and hypoparathyroid disorders. N Engl J Med (2000) 2.11
Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporos Int (2010) 1.74
A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. J Clin Endocrinol Metab (1998) 1.73
Effect of diphenylhydantoin and phenobarbital on overt and latent tetany. N Engl J Med (1966) 1.56
Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism. JAMA (1996) 1.56
Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab (2008) 1.46
Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol (2008) 1.44
Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. J Clin Endocrinol Metab (2010) 1.44
Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr (2003) 1.36
Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol (2002) 1.35
Adult coeliac disease. BMJ (2007) 1.30
Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ (2000) 1.28
A review of drug-induced hypocalcemia. J Bone Miner Metab (2009) 1.23
Postoperative hypoparathyroidism: medical and surgical therapeutic options. Thyroid (2009) 1.19
Hypoparathyroidism and pseudohypoparathyroidism. Arq Bras Endocrinol Metabol (2006) 1.13
Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med (2003) 1.07
Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism. Endocrine (2001) 1.01
Accuracy of methods to estimate ionized and "corrected" serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support. JPEN J Parenter Enteral Nutr (2004) 1.01
Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement. Arq Bras Endocrinol Metabol (2010) 0.97
Effects of calcium treatment on QT interval and QT dispersion in hypocalcemia. Am J Cardiol (2003) 0.95
Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism. Hum Mutat (2009) 0.93
Hypoparathyroidism: is it time for replacement therapy? J Clin Endocrinol Metab (2008) 0.92
Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res (1988) 0.91
Treatment of hypocalcemia in critical illness--part 1. Nutrition (2007) 0.89
Effect of parathyroid hormone administration in a patient with severe hypoparathyroidism caused by gain-of-function mutation of calcium-sensing receptor. Endocr J (2006) 0.86
Vitamin D deficiency. N Engl J Med (2007) 0.84
Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients. Nephrol Dial Transplant (2009) 0.83
Low serum total calcium concentration as a marker of low serum ionized calcium concentration in critically ill patients receiving specialized nutrition support. Nutr Clin Pract (2007) 0.82
Emergencies of calcium homeostasis. Rev Endocr Metab Disord (2003) 0.79
Association between hypoparathyroidism and defective T cell immunity in 22q11.2 deletion syndrome. J Clin Pathol (2010) 0.77
Treatment of acute hypocalcemia in critically ill multiple-trauma patients. JPEN J Parenter Enteral Nutr (2005) 0.76
Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab (2005) 5.64
Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res (2011) 2.30
Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J (2005) 2.15
Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Can Fam Physician (2014) 1.63
Osteonecrosis of the jaw and bisphosphonates. BMJ (2010) 1.41
Recognizing and reporting vertebral fractures: reducing the risk of future osteoporotic fractures. Can Assoc Radiol J (2007) 1.32
Primary hyperparathyroidism: Update on presentation, diagnosis, and management in primary care. Can Fam Physician (2011) 1.28
Recommendations for bone mineral density reporting in Canada: a shift to absolute fracture risk assessment. J Clin Densitom (2007) 1.15
Osteonecrosis of the jaw: new developments in an old disease. J Rheumatol (2008) 1.07
Bone densitometry: applications and limitations. J Obstet Gynaecol Can (2002) 0.99
Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis. Curr Med Res Opin (2013) 0.86
Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland. J Antimicrob Chemother (2012) 0.83
Dual-Energy X-Ray Absorptiometry Technical issues: the 2007 ISCD Official Positions. J Clin Densitom (2008) 0.81
Anabolic agents: a new chapter in the management of osteoporosis. J Obstet Gynaecol Can (2006) 0.81
Primary hyperparathyroidism. CMAJ (2011) 0.79
Asymptomatic primary hyperparathyroidism--commentary on current management. J Clin Densitom (2010) 0.78
Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program. Curr Med Res Opin (2015) 0.76
Approach to diagnosing celiac disease in patients with low bone mineral density or fragility fractures: multidisciplinary task force report. Can Fam Physician (2013) 0.75
Improving management of osteoporosis through simple changes in reporting fragility fractures. Can Assoc Radiol J (2013) 0.75
OSTEONECROSIS OF THE JAW: AN UPDATE FOR DENTISTS. J Can Dent Assoc (2015) 0.75
Response to Comments on "Diagnosis and Management of Osteoporosis of the Jaw: A Systematic Review and International Consensus". J Bone Miner Res (2015) 0.75
Primary hyperparathyroidism: diagnosis and management in 2017. Pol Arch Intern Med (2017) 0.75